Contineum Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Contineum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Contineum Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Contineum Therapeutics by Charles Schwab Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $829k | 43k | 19.14 |
2024-06-30 | $912k | 52k | 17.61 |